あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/06 | 1,910 | 1,910 | 1,840 | 1,868 | -45 | -2.4% | 186,000 |
| 2024/02/05 | 1,953 | 1,953 | 1,910 | 1,913 | -20 | -1% | 106,700 |
| 2024/02/02 | 1,969 | 1,969 | 1,918 | 1,933 | -46 | -2.3% | 114,700 |
| 2024/02/01 | 1,980 | 1,995 | 1,972 | 1,979 | -5 | -0.3% | 86,800 |
| 2024/01/31 | 1,973 | 1,993 | 1,958 | 1,984 | +9 | +0.5% | 53,500 |
| 2024/01/30 | 1,986 | 1,990 | 1,950 | 1,975 | -21 | -1.1% | 69,600 |
| 2024/01/29 | 2,000 | 2,024 | 1,979 | 1,996 | +8 | +0.4% | 76,700 |
| 2024/01/26 | 2,001 | 2,002 | 1,971 | 1,988 | -5 | -0.3% | 86,700 |
| 2024/01/25 | 1,959 | 2,000 | 1,957 | 1,993 | +52 | +2.7% | 136,900 |
| 2024/01/24 | 1,907 | 1,954 | 1,907 | 1,941 | +36 | +1.9% | 79,300 |
| 2024/01/23 | 1,885 | 1,917 | 1,880 | 1,905 | +24 | +1.3% | 70,600 |
| 2024/01/22 | 1,852 | 1,882 | 1,850 | 1,881 | +34 | +1.8% | 36,700 |
| 2024/01/19 | 1,872 | 1,872 | 1,839 | 1,847 | -27 | -1.4% | 38,300 |
| 2024/01/18 | 1,850 | 1,878 | 1,850 | 1,874 | +26 | +1.4% | 66,900 |
| 2024/01/17 | 1,861 | 1,879 | 1,847 | 1,848 | -13 | -0.7% | 79,400 |
| 2024/01/16 | 1,850 | 1,876 | 1,850 | 1,861 | +11 | +0.6% | 49,500 |
| 2024/01/15 | 1,831 | 1,855 | 1,825 | 1,850 | +15 | +0.8% | 82,400 |
| 2024/01/12 | 1,904 | 1,904 | 1,828 | 1,835 | +11 | +0.6% | 122,700 |
| 2024/01/11 | 1,856 | 1,863 | 1,812 | 1,824 | -27 | -1.5% | 85,700 |
| 2024/01/10 | 1,821 | 1,860 | 1,821 | 1,851 | +16 | +0.9% | 67,300 |
| 2024/01/09 | 1,833 | 1,838 | 1,821 | 1,835 | +10 | +0.5% | 53,300 |
| 2024/01/05 | 1,820 | 1,845 | 1,820 | 1,825 | +11 | +0.6% | 33,900 |
| 2024/01/04 | 1,800 | 1,819 | 1,787 | 1,814 | +30 | +1.7% | 52,300 |
| 2023/12/29 | 1,779 | 1,788 | 1,775 | 1,784 | +20 | +1.1% | 38,000 |
| 2023/12/28 | 1,781 | 1,781 | 1,752 | 1,764 | -17 | -1% | 37,900 |
| 2023/12/27 | 1,765 | 1,784 | 1,762 | 1,781 | +12 | +0.7% | 64,300 |
| 2023/12/26 | 1,768 | 1,777 | 1,760 | 1,769 | +1 | +0.1% | 44,400 |
| 2023/12/25 | 1,782 | 1,790 | 1,756 | 1,768 | +26 | +1.5% | 50,700 |
| 2023/12/22 | 1,715 | 1,745 | 1,714 | 1,742 | +27 | +1.6% | 37,400 |
| 2023/12/21 | 1,721 | 1,723 | 1,712 | 1,715 | -29 | -1.7% | 46,000 |
| 2023/12/20 | 1,733 | 1,748 | 1,733 | 1,744 | +5 | +0.3% | 46,900 |
| 2023/12/19 | 1,730 | 1,739 | 1,716 | 1,739 | +9 | +0.5% | 45,300 |
| 2023/12/18 | 1,740 | 1,740 | 1,718 | 1,730 | -14 | -0.8% | 37,300 |
| 2023/12/15 | 1,772 | 1,774 | 1,716 | 1,744 | -46 | -2.6% | 90,200 |
| 2023/12/14 | 1,807 | 1,810 | 1,780 | 1,790 | +2 | +0.1% | 59,800 |
| 2023/12/13 | 1,773 | 1,790 | 1,766 | 1,788 | +14 | +0.8% | 39,100 |
| 2023/12/12 | 1,777 | 1,780 | 1,765 | 1,774 | -3 | -0.2% | 40,300 |
| 2023/12/11 | 1,756 | 1,779 | 1,752 | 1,777 | +19 | +1.1% | 37,000 |
| 2023/12/08 | 1,784 | 1,784 | 1,749 | 1,758 | -8 | -0.5% | 62,200 |
| 2023/12/07 | 1,779 | 1,795 | 1,763 | 1,766 | -27 | -1.5% | 41,300 |
| 2023/12/06 | 1,784 | 1,801 | 1,784 | 1,793 | -3 | -0.2% | 47,800 |
| 2023/12/05 | 1,800 | 1,821 | 1,796 | 1,796 | -5 | -0.3% | 55,500 |
| 2023/12/04 | 1,825 | 1,825 | 1,788 | 1,801 | -32 | -1.7% | 67,300 |
| 2023/12/01 | 1,821 | 1,849 | 1,812 | 1,833 | +12 | +0.7% | 60,000 |
| 2023/11/30 | 1,790 | 1,826 | 1,782 | 1,821 | +21 | +1.2% | 46,500 |
| 2023/11/29 | 1,831 | 1,835 | 1,800 | 1,800 | -21 | -1.2% | 64,200 |
| 2023/11/28 | 1,829 | 1,840 | 1,801 | 1,821 | +21 | +1.2% | 69,000 |
| 2023/11/27 | 1,834 | 1,837 | 1,794 | 1,800 | ±0 | ±0% | 87,700 |
| 2023/11/24 | 1,807 | 1,822 | 1,795 | 1,800 | +1 | +0.1% | 83,300 |
| 2023/11/22 | 1,772 | 1,820 | 1,767 | 1,799 | +25 | +1.4% | 54,400 |
351～
400
件表示中 / 1048件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 235,700円 | +16.9% | +33.2% | 2.33% | 12.86倍 | 1.02倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ハートシード | 348,000円 | +174.2% | - | 0.00% | - | 10.44倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| 栄研化 | 203,200円 | +4.1% | -3.1% | 2.85% | 17.62倍 | 1.54倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| タウンズ | 54,500円 | +4.6% | +6.1% | 5.14% | 9.30倍 | 3.44倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| ヘリオス | 51,700円 | +150.0% | - | 0.00% | - | 26.23倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム
